ผลของการพัฒนาโปรแกรมการส่งเสริมสมรรถนะแห่งตนในการดูแลตนเอง ต่อพฤติกรรมการดูแลตนเอง และผลลัพธ์ทางคลินิกในผู้ป่วยโรคไทรอยด์เป็นพิษชนิดเกรฟส์ที่เข้ารับการรักษาในโรงพยาบาลบ้านไผ่ จังหวัดขอนแก่น

Siriporn Thipyophat

Authors

Siriporn Thipyophat -

Keywords:

Self-efficacy enhancement, Self-care behavior, Clinical outcomes, Graves’ disease

Abstract

This quasi-experimental study employed a two-group pretest–posttest design to examine the effects of a self-efficacy enhancement program on self-care behaviors and clinical outcomes among patients with Graves’ disease. A total of 60 patients receiving treatment at Ban Phai Hospital, Khon Kaen Province, were recruited between July to October 2025 and allocated into an experimental group (n = 30) and a control group (n = 30). Research instruments included (1) the self-efficacy enhancement program based on Bandura’s framework, (2) a demographic data form, (3) a self-care behavior questionnaire, and (4) a clinical outcomes recording form assessing TSH, Free T3, Free T4 levels, and major clinical symptoms. Data were analyzed using descriptive statistics, independent t-tests, and paired t-tests.

The results indicated that participants in the experimental group demonstrated significantly higher post-intervention self-care behavior scores compared to the control group (mean = 79.47, SD = 12.95 vs. mean = 66.63, SD = 10.72; t = 4.182, p < .001). The mean difference was 12.83, with a large effect size (Cohen’s d = 1.08), indicating substantial effectiveness of the intervention in improving self-care behavior. However, clinical outcomes, including TSH, free T3, free T4 levels, and clinical symptoms, showed no statistically significant differences between groups (p > .05).

References

Davies TF, Andersen S, Latif R, Nagayama Y, Barbesino G, Brito M, Eckstein AK, Stagnaro-Green A, Kahaly GJ.(2020). Graves' disease. Nat Rev Dis Primers. 2020;6(1):52. https://doi.org/10.1038/s41572-020-0184-y

Fukao A, Takamatsu J, Arishima T, Tanaka M, Kawai T, Okamoto Y, Miyauchi A, Imagawa A.(2019). Graves' disease and mental disorders. J Clin Transl Endocrinol. 2019;19:100207. https://doi.org/10.1016/j.jcte.2019.100207

Antonelli A, Ferrari SM, Ragusa F, Elia G, Paparo SR, Ruffilli I, Patrizio A, Giusti C, Gonnella D, Cristaudo A, Foddis R, Shoenfeld Y, Fallahi P.(2020). Graves' disease: Epidemiology, genetic and environmental risk factors and viruses. Best Pract Res Clin Endocrinol Metab. 2020;34(1):101387. https://doi.org/10.1016/j.beem.2020.101387

Toro-Tobon D, Stan MN.(2024). Graves’ disease and the manifestations of thyrotoxicosis. In: Feingold KR, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.

Bartalena L, Tanda ML.(2022). Current concepts regarding Graves' orbitopathy. J Intern Med. 2022;292(5):692-716. https://doi.org/10.1111/joim.13524

Lee SY, Pearce EN.(2023). Hyperthyroidism: A Review. JAMA. 2023;330(15):1472-1483. https://doi.org/10.1001/jama.2023.19052

Zuntini JVR, Atala YB, Parisi MCR, Oliveira DC, Zantut-Wittmann DE.(20204). Cardiac Autonomic Neuropathy in Graves' Disease: Smoking and Age as Predictive Factors. Endocr Pract. 2024;30(9):822-9. https://doi.org/10.1016/j.eprac.2024.05.010

Hazkani I, Stein E, Samis J, Josefson J, Maddalozzo J, Johnston D, Huang A, Rastatter J.(2022). The effect of hyperthyroidism at thyroidectomy on complication rates in children with Graves' disease. Int J Pediatr Otorhinolaryngol. 2022;163:111360. https://doi.org/10.1016/j.ijporl.2022.111360

Wiersinga WM, Poppe KG, Effraimidis G.(2023). Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis. Lancet Diabetes Endocrinol. 2023;11(4):282-98. https://doi.org/10.1016/S2213-8587(23)00005-0

Holmberg M, Malmgren H, Berglund PF, Johansson B, Nyström HF.(2024). Psychiatric complications in Graves' disease. Eur Thyroid J. 2024;13(1):e230247. https://doi.org/10.1530/ETJ-23-0247

Piekiełko-Witkowska A, Duda MK, Bogusławska J, Mackiewicz U.(2025). The impact of autoimmune thyroid disease on cognitive and psychiatric disorders: focus on clinical, pre-clinical and molecular studies. Eur Thyroid J. 2025;14(3):e240406. https://doi.org/10.1530/ETJ-24-0406

Mengistu HS, Getahun KT, Alemayehu L, Gezahign S.(2022). Cost-Effectiveness Analysis of Antithyroid Drug (Propylthiouracil) Compared to Radioactive Iodine for the Treatment of Graves' Disease in Ethiopia. Clinicoecon Outcomes Res. 2022;14:221-9. https://doi.org/10.2147/CEOR.S350984

Brito JP, Payne S, Singh Ospina N, Rodriguez-Gutierrez R, Maraka S, Sangaralingham LR, Iñiguez-Ariza NM, Montori VM, Stan MN.(2020). Patterns of Use, Efficacy, and Safety of Treatment Options for Patients with Graves' Disease: A Nationwide Population-Based Study. Thyroid. 2020;30(3):357-64. https://doi.org/10.1089/thy.2019.0132

Bartalena L, Piantanida E, Gallo D, Ippolito S, Tanda ML.(2022). Management of Graves' hyperthyroidism: present and future. Expert Rev Endocrinol Metab. 2022;17(2):153-66. https://doi.org/10.1080/17446651.2022.2052044

Lutterman SL, Zwaveling-Soonawala N, Verberne HJ, Verburg FA, van Trotsenburg ASP, Mooij CF.(2021). The Efficacy and Short- and Long-Term Side Effects of Radioactive Iodine Treatment in Pediatric Graves' Disease: A Systematic Review. Eur Thyroid J. 2021;10(5):353-63. https://doi.org/10.1159/000517174

Lee SY, Pearce EN.(2023). Hyperthyroidism: A Review. JAMA. 2023;330(15):1472-83. https://doi.org/10.1001/jama.2023.19052

โสภณวิชญ์ ถิ่นว่อง.(2567). ปัจจัยเสี่ยงในการกลับเป็นซ้ำของผู้ป่วยโรคไทรอยด์เป็นพิษชนิดเกรฟส์หลังการรักษาด้วยยาต้านไทรอยด์ โรงพยาบาลดำเนินสะดวก. วารสารวิจัยเพื่อการส่งเสริมสุขภาพและคุณภาพชีวิต. 2567;4(3):88-98.

กรกฎ สิรเกรียงไกร.(2566). อัตราการรักษาสำเร็จและปัจจัยที่สัมพันธ์กับการตอบสนองการรักษาในผู้ป่วยโรคไทรอยด์เกรฟส์ด้วยสารรังสีไอโอดีนแบบครั้งแรกในโรงพยาบาลสุราษฎร์ธานี. วารสารวิชาการแพทย์และสาธารณสุขเขตสุขภาพที่ 3. 2566;21(1):8-14

Bandura A.(1997). Self-efficacy: The exercise of control. New York: W.H. Freeman; 1997.

Dinh TT, Bonner A.(2023). Exploring the relationships between health literacy, social support, self-efficacy and self-management in adults with multiple chronic diseases. BMC health services research. 2023;23(1):923. https://doi.org/10.1186/s12913-023-09907-5

Hoang TD, Stocker DJ, Chou EL, Burch HB.(2022). 2022 Update on Clinical Management of Graves Disease and Thyroid Eye Disease. Endocrinol Metab Clin North Am. 2022;51(2):287-304. https://doi.org/10.1016/j.ecl.2021.12.004

Luo ZN, Li K, Chen AQ, et al.(2024). The influence of family health on self-efficacy in patients with chronic diseases: the mediating role of perceived social support and the moderating role of health literacy. BMC Public Health. 2024;24(1):3398. https://doi.org/10.1186/s12889-024-20906-x

Gao Y, Zheng Y, He Y, Lin J, Liu F, Fu J, Lin R.(2024). The relationship between self-efficacy, health literacy, and quality of life in patients with chronic diseases: a cross-sectional study in China. Front Public Health. 2024;12:1430202. https://doi.org/10.3389/fpubh.2024.1430202

Johansson B, Holmberg M, Skau S, Malmgren H, Filipsson Nyström H.(2023). The relationship between mental fatigue, depression, and cognition in Graves' disease. Eur Thyroid J. 2023;12(4):e230040. https://doi.org/10.1530/ETJ-23-0040

Giordani I, Sykiotis GP.(2025). A short review of current knowledge regarding long-term treatment of Graves' disease with antithyroid drugs. Hormones (Athens). 2025;24(2):347-58. https://doi.org/10.1007/s42000-024-00618-y